CCL2 and neoplasm: In a mouse model of hepatocellular tumor-initiating cells, treatment with palbosiclib reduced tumor development and promoted a senescence-associated secretory phenotype with induction of chemokines CXCL10 and CCL2 and attraction of tumor-suppressing macrophages [104]